STXS Key Statistics, Chart & Performance
The current stock price of STXS is 2.25 USD. In the past month the price decreased by -19.59%. In the past year, price increased by 5.88%.
STXS Latest News, Press Relases and Analysis
STXS Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 25.31 | 219.65B | ||
| ISRG | INTUITIVE SURGICAL INC | 65.94 | 201.26B | ||
| BSX | BOSTON SCIENTIFIC CORP | 33.57 | 146.79B | ||
| SYK | STRYKER CORP | 27.84 | 140.23B | ||
| IDXX | IDEXX LABORATORIES INC | 58.11 | 58.51B | ||
| BDX | BECTON DICKINSON AND CO | 13.21 | 54.59B | ||
| EW | EDWARDS LIFESCIENCES CORP | 32.96 | 49.16B | ||
| RMD | RESMED INC | 25.34 | 36.62B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 17.48 | 36.54B | ||
| DXCM | DEXCOM INC | 34.65 | 25.14B | ||
| PODD | INSULET CORP | 67.61 | 21.74B | ||
| ZBH | ZIMMER BIOMET HOLDINGS INC | 11.64 | 18.66B |
Related stock screener links
About STXS
Company Profile
Stereotaxis, Inc. designs, manufactures and markets robotic magnetic navigation systems for use in a hospital's interventional surgical suite to enhance the treatment of arrhythmias and coronary artery disease. The company is headquartered in St. Louis, Missouri and currently employs 139 full-time employees. The company went IPO on 2004-08-12. Its proprietary robotic technology, Robotic Magnetic Navigation (RMN), fundamentally transforms endovascular interventions using precise computer-controlled magnetic fields to directly control the tip of flexible interventional catheters or devices. The Company’s primary products include the Genesis RMN System, the Odyssey Solution, and other related devices. Through its strategic relationships with fluoroscopy system manufacturers, providers of catheters and electrophysiology mapping systems, and other parties, the Company offers its customers x-ray systems and other accessory devices. The Genesis RMN System is designed to enable physicians to complete more complex interventional procedures by providing image-guided delivery of catheters through the blood vessels and chambers of the heart to treatment sites.
Company Info
STEREOTAXIS INC
710 N Tucker Blvd, Ste 110
St. Louis MISSOURI 63108 US
CEO: David L. Fischel
Employees: 139
Phone: 13146786100
STEREOTAXIS INC / STXS FAQ
What does STEREOTAXIS INC do?
Stereotaxis, Inc. designs, manufactures and markets robotic magnetic navigation systems for use in a hospital's interventional surgical suite to enhance the treatment of arrhythmias and coronary artery disease. The company is headquartered in St. Louis, Missouri and currently employs 139 full-time employees. The company went IPO on 2004-08-12. Its proprietary robotic technology, Robotic Magnetic Navigation (RMN), fundamentally transforms endovascular interventions using precise computer-controlled magnetic fields to directly control the tip of flexible interventional catheters or devices. The Company’s primary products include the Genesis RMN System, the Odyssey Solution, and other related devices. Through its strategic relationships with fluoroscopy system manufacturers, providers of catheters and electrophysiology mapping systems, and other parties, the Company offers its customers x-ray systems and other accessory devices. The Genesis RMN System is designed to enable physicians to complete more complex interventional procedures by providing image-guided delivery of catheters through the blood vessels and chambers of the heart to treatment sites.
What is the current price of STXS stock?
The current stock price of STXS is 2.25 USD. The price decreased by -3.85% in the last trading session.
Does STXS stock pay dividends?
STXS does not pay a dividend.
What is the ChartMill rating of STEREOTAXIS INC stock?
STXS has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 2 out of 10.
On which exchange is STXS stock listed?
STXS stock is listed on the NYSE Arca exchange.
Can you provide the PE ratio for STXS stock?
STEREOTAXIS INC (STXS) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.28).
What is the Short Interest ratio of STEREOTAXIS INC (STXS) stock?
The outstanding short interest for STEREOTAXIS INC (STXS) is 4.6% of its float.
STXS Technical Analysis
STXS Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to STXS. The financial health of STXS is average, but there are quite some concerns on its profitability.
STXS Financial Highlights
Over the last trailing twelve months STXS reported a non-GAAP Earnings per Share(EPS) of -0.28.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -59.84% | ||
| ROE | -364.9% | ||
| Debt/Equity | 0 |
STXS Forecast & Estimates
9 analysts have analysed STXS and the average price target is 4.34 USD. This implies a price increase of 92.67% is expected in the next year compared to the current price of 2.25.
For the next year, analysts expect an EPS growth of 21.8% and a revenue growth 26.96% for STXS